Accelerate your journey to population health. Pathways to Population Health aims to help health care organizations accelerate their individual and collective efforts to improve health, well-being, and equity within communities.
2018 Summit Session 1
2018 Summit Session 2
Dräger Medical is recalling the Fabius Anesthesia machines due to excessive oil that was not removed at the time of production. Such excess oil may interfere with the position detector of the ventilation motor during operation and may cause ventilation to fail. A halt in ventilation may lead to serious adverse health consequences, including patient injury or death.
The FDA has received reports associated with the use of these devices in the treatment of unruptured brain aneurysms that suggest some events of peri-procedural stroke and/or death may have been related to procedural risks or patient selection related factors. These factors include patients who had serious co-morbidities resulting in a reduced life expectancy, or who were intolerant to required anticoagulation or anti-platelet therapy.
Piperacillin and Tazobactam for Injection, USP 3.375 g by AuroMedics Pharma: Recall: Exposure to particulate matter may result in local irritation/swelling or more serious outcomes.
Ampicillin and Sulbactam for Injection USP, 3 g/Single-Dose Vials by AuroMedics Pharma: Recall - Exposure to particulate may result in local site reaction, thromboembolic events and systemic immune response.
This article describes a "dosing" approach that establishes and deploys targeted levels of improvement knowledge and skills throughout an organization to build improvement capacity and capability.
Governmental and private groups to partner on population health challenges
This article discusses National Healthcare Decision Day (NHDD) and its connection to IHI's The Conversation Project as it relates to Barbara Bush's comfort care decision.
This article contains a video interview with Dr. Tejal Gandhi, IHI Chief Clinical and Safety Officer, as part of Modern Healthcare's ongoing series, No One Is Safe From Harm.
This article from Brazil includes the results from Phase II of IHI's Parto Adequado.
In this interview, Barbara Balik, EdD, MS, RN, senior faculty at the Institute of Healthcare Improvement, recognizes the positives and negatives of electronic health records.
The Harvard Medical School (HMS) Center for Primary Care led a 4-year initiative, called the Academic Innovations Collaborative, to transform primary care delivery in the clinics where most Harvard trainees learn how to practice primary care. IHI assisted in this initiative and this article includes the initial results.
This article discusses what makes hospital employees – especially clinicians – happy at work and engaged in their jobs and includes commentary from Barbara Balik, RN, EdD, senior faculty at the Institute for Healthcare Improvement.
In the midst of an ongoing shift to value-based care, IHI Summit attendees will learn strategies and tactics to design care for the whole person.
In this article, Dr. Donald Berwick shares a personal story that suggests that the US has a long way to go on quality and safety in health care.
The FDA is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body’s infection-fighting immune system. This can cause severe inflammation throughout the body and lead to hospitalization and death, especially if the reaction is not diagnosed and treated quickly. As a result, we are requiring a new warning about this risk be added to the prescribing information in the lamotrigine drug labels. The immune system reaction, called hemophagocytic lymphohistiocytosis (HLH), causes an uncontrolled response by the immune system. HLH typically presents as a persistent fever, usually greater than 101°F, and it can lead to severe problems with blood cells and organs throughout the body such as the liver, kidneys, and lungs.
FDA is currently evaluating data which suggests that potentially inaccurate MR thermometry information can be displayed during treatment. Posted 04/25/2018
This report discusses barriers to integrating behavioral health in the ED; presents the results of a literature scan of existing models to address behavioral health needs in the ED and in communities; and identifies five drivers (emerging from six key themes from existing approaches) that form the building blocks of a theory of change for making improvements in this area.